Overactive Bladder in Female Patients
Conditions
Interventions
Control Group:Solifenacin Succinate Tablets
Experimental Group:1. Urethral Dilation: A domestically produced 26F-30F dilator was selected based on the urethral caliber. The procedure was performed once per week for a total duration of 6 weeks.
Sponsors
The People's Hospital of Linxia
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years; 2.Meeting the diagnostic criteria for overactive bladder (OAB); 3.Normal hepatic and renal function; 4.Absence of psychiatric disorders; 5.Tolerance to the therapeutic methods employed in this study.
Exclusion criteria
Exclusion criteria: 1.Presence of bladder outlet obstruction; 2.Comorbidities including urinary tract infection, urolithiasis, or other urological conditions such as neurogenic bladder; 3.Pregnancy or lactation; 4.Presence of intellectual disability; 5.Severe somatic diseases or physical immobility.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overactive bladder score, OABSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensory volume of first urination, FDV;Maximum bladder capacity, MCBC;Maximum single urine output, MVV;Safety; | — |
Countries
China
Contacts
Public ContactShengming Ma
The People's Hospital of Linxia
Outcome results
None listed